November 3rd, 2026Complement inhibition in GA: Timing, safety, and follow-upMurtaza K. Adam, MD, reviews 3 patient cases to explore referral patterns, neovascularization after treatment, and barriers to care.Read more
November 2nd, 2026NeuroOp Guru: Flow-diverting stents and vision — safe or risky?Andrew G. Lee, MD, and Drew Carey, MD, break down the visual safety of flow-diverting stents for carotid-ophthalmic aneurysms.Read more
October 30th, 2026Practical ways to extend anti-VEGF control in RVO, AMD, and DMEJordana G. Fein, MD, MS, points to agent selection, payer requirements, and real-world treatment response across 3 retina cases.Read more
October 21st, 2026Demodex blepharitis: Diagnosis, treatment response, and recurrenceHimani Goyal, MD, reviews a patient case and discusses what a multispecialty group is seeing in practice.Read more
October 21st, 2026Brepocitinib meets all Phase 3 end points in noninfectious uveitisCLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.Read more
November 4th, 2026Looking beyond visual acuity in macular telangiectasiaClinical Forum cases examine symptoms, progression, and treatment response.Read more
November 4th, 2026The One Thing: IOL choices, gene therapy and TKI trials, the patient in the chair | Episode 5Uday Devgan, MD, FACS, Jordana G. Fein, MD, MS, and Carl D. Regillo, MD, FASRS, point to IOL education, emerging retina therapies, and treatment burden.Read more
October 31st, 2026Stool biomarker uncovers silent bowel disease in uveitis patientsA simple stool test may reveal hidden bowel disease in patients whose only symptoms are in their eyes.Read more